Emile G. Plise

2.8k total citations
39 papers, 876 citations indexed

About

Emile G. Plise is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Emile G. Plise has authored 39 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 21 papers in Molecular Biology and 7 papers in Pharmacology. Recurrent topics in Emile G. Plise's work include Drug Transport and Resistance Mechanisms (17 papers), Pharmacogenetics and Drug Metabolism (5 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). Emile G. Plise is often cited by papers focused on Drug Transport and Resistance Mechanisms (17 papers), Pharmacogenetics and Drug Metabolism (5 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). Emile G. Plise collaborates with scholars based in United States, France and Switzerland. Emile G. Plise's co-authors include Laurent Salphati, Jonathan Cheong, Jae H. Chang, Susan Wong, Jodie Pang, Xiaolin Zhang, Molly Lin, Leslie B. Lee, Alan G. Olivero and Justin Q. Ly and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Analytical Chemistry.

In The Last Decade

Emile G. Plise

38 papers receiving 823 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emile G. Plise United States	17	493	312	115	94	84	39	876
Selvi Durmuş Netherlands	16	482 1.0×	568 1.8×	80 0.7×	134 1.4×	85 1.0×	24	1.0k
Joachim Blanz Germany	14	536 1.1×	202 0.6×	51 0.4×	31 0.3×	98 1.2×	31	967
Marek Mirowski Poland	18	459 0.9×	549 1.8×	51 0.4×	143 1.5×	64 0.8×	106	1.1k
Jodie Pang United States	14	267 0.5×	146 0.5×	43 0.4×	30 0.3×	65 0.8×	29	459
Sharon Lobert United States	19	577 1.2×	389 1.2×	60 0.5×	66 0.7×	91 1.1×	42	1.1k
Mary J. Kuffel United States	14	272 0.6×	262 0.8×	190 1.7×	24 0.3×	59 0.7×	30	734
Peter Norman United Kingdom	18	436 0.9×	202 0.6×	44 0.4×	28 0.3×	267 3.2×	100	1.3k
Judit Cserepes Hungary	7	416 0.8×	472 1.5×	39 0.3×	78 0.8×	45 0.5×	10	786
Vidula Sukhatme United States	8	353 0.7×	190 0.6×	48 0.4×	21 0.2×	73 0.9×	17	751
Wanghai Zhang United States	11	387 0.8×	249 0.8×	75 0.7×	19 0.2×	67 0.8×	16	683

Countries citing papers authored by Emile G. Plise

Since Specialization

Citations

This map shows the geographic impact of Emile G. Plise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emile G. Plise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emile G. Plise more than expected).

Fields of papers citing papers by Emile G. Plise

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emile G. Plise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emile G. Plise. The network helps show where Emile G. Plise may publish in the future.

Co-authorship network of co-authors of Emile G. Plise

This figure shows the co-authorship network connecting the top 25 collaborators of Emile G. Plise. A scholar is included among the top collaborators of Emile G. Plise based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emile G. Plise. Emile G. Plise is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ma, Bin, Jakob Fuhrmann, S. Cyrus Khojasteh, et al.. (2025). Overcoming Challenges in the Metabolism of Peptide Therapeutics: Strategies and Case Studies for Clinical Success. Journal of Medicinal Chemistry. 68(24). 25689–25707.

Adaligil, Emel, Nataliya Popovych, Satoshi Ono, et al.. (2024). Membrane Permeability in a Large Macrocyclic Peptide Driven by a Saddle-Shaped Conformation. Journal of the American Chemical Society. 146(7). 4582–4591. 11 indexed citations

Salphati, Laurent, Jodie Pang, Emile G. Plise, et al.. (2024). Preclinical assessment of the PI3Kα selective inhibitor inavolisib and prediction of its pharmacokinetics and efficacious dose in human. Xenobiotica. 54(10). 808–820. 5 indexed citations

Salphati, Laurent, Jodie Pang, Bruno Alicke, et al.. (2024). Preclinical characterization of the absorption and disposition of the brain penetrant PI3K/mTOR inhibitor paxalisib and prediction of its pharmacokinetics and efficacy in human. Xenobiotica. 54(2). 64–74. 5 indexed citations

Bowman, Christine M., Fang Ma, Emile G. Plise, et al.. (2023). Evaluation of bottom‐up modeling of the blood–brain barrier to improve brain penetration prediction via physiologically based pharmacokinetic modeling. Biopharmaceutics & Drug Disposition. 44(1). 60–70. 3 indexed citations

Rosenberg, Scott, Fergus Shanahan, Sayumi Yamazoe, et al.. (2023). Ternary complex dissociation kinetics contribute to mutant-selective EGFR degradation. Cell chemical biology. 30(2). 175–187.e15. 10 indexed citations

Ji, Shaofei, Wei Wang, Susan Wong, et al.. (2022). An Integrated Strategy for Assessing the Metabolic Stability and Biotransformation of Macrocyclic Peptides in Drug Discovery toward Oral Delivery. Analytical Chemistry. 94(4). 2032–2041. 13 indexed citations

Chiang, Po‐Chang, Jia Liu, Karthik Nagapudi, et al.. (2022). Elucidating a Potential Mechanism of Permeability Enhancer Sodium N-[8-(2-hydroxybenzoyl) amino] Caprylate in Rats: Evidence of Lymphatic Absorption of Cyanocobalamin using the Mesenteric Lymph Duct Cannulated Rat. Journal of Pharmaceutical Sciences. 111(12). 3417–3423. 2 indexed citations

Chiang, Po‐Chang, Karthik Nagapudi, Jia Liu, et al.. (2019). An Integrated Analysis of Solid Form Change Impact on Solubility and Permeability: Case Study of Oral Exposure in Rats of an RAR Related Orphan Receptor C Inhibitor. Journal of Pharmaceutical Sciences. 108(7). 2256–2263. 3 indexed citations

10.

Chang, Jae H., Justin Q. Ly, Emile G. Plise, et al.. (2014). Differential Effects of Rifampin and Ketoconazole on the Blood and Liver Concentration of Atorvastatin in Wild-Type and Cyp3a and Oatp1a/b Knockout Mice. Drug Metabolism and Disposition. 42(6). 1067–1073. 23 indexed citations

11.

Hanson, Jesse E., Hank La, Emile G. Plise, et al.. (2013). SAHA Enhances Synaptic Function and Plasticity In Vitro but Has Limited Brain Availability In Vivo and Does Not Impact Cognition. PLoS ONE. 8(7). e69964–e69964. 93 indexed citations

12.

Pai, Rama, Dorothy French, Ning Ma, et al.. (2012). Antibody-Mediated Inhibition of Fibroblast Growth Factor 19 Results in Increased Bile Acids Synthesis and Ileal Malabsorption of Bile Acids in Cynomolgus Monkeys. Toxicological Sciences. 126(2). 446–456. 62 indexed citations

13.

Salphati, Laurent, Jodie Pang, Emile G. Plise, et al.. (2012). Preclinical Assessment of the Absorption and Disposition of the Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor GDC-0980 and Prediction of Its Pharmacokinetics and Efficacy in Human. Drug Metabolism and Disposition. 40(9). 1785–1796. 30 indexed citations

14.

Choo, Edna F., Marcia Belvin, Jason Boggs, et al.. (2012). Preclinical Disposition of GDC-0973 and Prospective and Retrospective Analysis of Human Dose and Efficacy Predictions. Drug Metabolism and Disposition. 40(5). 919–927. 28 indexed citations

15.

Salphati, Laurent, Jodie Pang, Emile G. Plise, et al.. (2011). Preclinical pharmacokinetics of the novel PI3K inhibitor GDC-0941 and prediction of its pharmacokinetics and efficacy in human. Xenobiotica. 41(12). 1088–1099. 20 indexed citations

16.

Liederer, Bianca M., Xingrong Liu, Leonid M. Berezhkovskiy, et al.. (2011). Preclinical stereoselective disposition and toxicokinetics of two novel MET inhibitors. Xenobiotica. 42(5). 456–465. 1 indexed citations

17.

Plise, Emile G., Daniel Tran, & Laurent Salphati. (2010). Semi-Automated Protein Binding Methodology Using Equilibrium Dialysis and A Novel Mixed-Matrix Cassette Approach. Journal of Pharmaceutical Sciences. 99(12). 5070–5078. 6 indexed citations

18.

Liederer, Bianca M., Leonid M. Berezhkovskiy, Brian J. Dean, et al.. (2010). Preclinical absorption, distribution, metabolism, excretion, and pharmacokinetic–pharmacodynamic modelling ofN-(4-(3-((3S,4R)-1-ethyl-3-fluoropiperidine-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-4-yloxy)-3-fluorophenyl)-2-(4-fluorophenyl)-3-oxo-2,3-dihydropyridazine-4-carboxamide, a novel MET kinase inhibitor. Xenobiotica. 41(4). 327–339. 7 indexed citations

19.

Salphati, Laurent, Leslie B. Lee, Jodie Pang, Emile G. Plise, & Xiaolin Zhang. (2010). Role of P-Glycoprotein and Breast Cancer Resistance Protein-1 in the Brain Penetration and Brain Pharmacodynamic Activity of the Novel Phosphatidylinositol 3-Kinase Inhibitor GDC-0941. Drug Metabolism and Disposition. 38(9). 1422–1426. 20 indexed citations

20.

Salphati, Laurent, Emile G. Plise, & Guangmin Li. (2009). Expression and activity of the efflux transporters ABCB1, ABCC2 and ABCG2 in the human colorectal carcinoma cell line LS513. European Journal of Pharmaceutical Sciences. 37(3-4). 463–468. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact